Plasma exchange for Guillain-Barré syndrome (Q24202179)

4

0 references

Sylvie Chevret

2

object named as

Sylvie Chevret

0 references

author name string

Jean Claude Raphaël

1

0 references

Richard AC Hughes

Cochrane Database of Systematic Reviews

3

0 references

publication date

11 July 2012

0 references

published in

0 references

cites work

Pentastarch instead of albumin as replacement fluid for therapeutic plasma exchange. The Canadian Apheresis Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001798.PUB2

Assessment of current diagnostic criteria for Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001798.PUB2

Controlled trial prednisolone in acute polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001798.PUB2

Immunotherapy for Guillain-Barre syndrome: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001798.PUB2

Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001798.PUB2

Therapeutic Plasma Exchange

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001798.PUB2

Prognostic factors of Guillain-Barré syndrome after intravenous immunoglobulin or plasma exchange. Dutch Guillain-Barré Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001798.PUB2

Plasma exchange for Guillain-Barré syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001798.PUB2

Circulating Demyelinating Factors in Acute Idiopathic Polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001798.PUB2

7 January 2021

Demyelination induced by serum from patients with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001798.PUB2

7 January 2021

Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001798.PUB2

7 January 2021

Plasmapheresis and Guillain-Barré syndrome: analysis of prognostic factors and the effect of plasmapheresis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001798.PUB2

7 January 2021

Plasma exchange in Guillain-Barré syndrome: one-year follow-up. French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001798.PUB2

7 January 2021

Appropriate number of plasma exchanges in Guillain-Barré syndrome. The French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001798.PUB2

7 January 2021

The North American study of plasmapheresis in the Guillain-Barre syndrome. The Guillain-Barre' Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001798.PUB2

7 January 2021

Plasma exchange and prednisone in acute inflammatory polyradiculoneuropathy: a controlled randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001798.PUB2

7 January 2021

Manual plasmapheresis in the treatment of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001798.PUB2

7 January 2021

Cost analysis of plasma-exchange therapy for the treatment of Guillain-Barré syndrome. French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001798.PUB2

7 January 2021

Treatment of acute polyneuropathy by plasma exchange

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001798.PUB2

7 January 2021

Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001798.PUB2

7 January 2021

Controlled trial of plasma exchange in acute inflammatory polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001798.PUB2

7 January 2021

A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001798.PUB2

7 January 2021

Plasmapheresis versus plasma perfusion in acute Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001798.PUB2

7 January 2021

Plasma exchange therapy reduces the nursing care needed in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001798.PUB2

7 January 2021

Plasma Exchange as a Therapy for Guillain‐Barré Syndrome with Immune Complexes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001798.PUB2

7 January 2021

Plasma exchange and prednisone in Guillain-Barré syndrome: a controlled randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001798.PUB2

7 January 2021

Guillain-Barré syndrome: quantitative measurement of plasma exchange therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001798.PUB2

7 January 2021

CSF filtration is an effective treatment of Guillain-Barré syndrome: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001798.PUB2

7 January 2021